Literature DB >> 17597398

13C-urea breath test values and Helicobacter pylori eradication.

Angelo Zullo1, Federico Perna, Chiara Ricci, Cesare Hassan, Andrea Tampieri, Vincenzo De Francesco, Sergio Morini, Dino Vaira.   

Abstract

Delta over baseline (DOB) values of 13C-urea breath test (UBT) have been shown to be predictive of H. pylori eradication following therapy. This was a post hoc analysis of a large, double-blind, randomized trial. Consecutive patients with a positive UBT underwent upper endoscopy. H. pylori strains were tested for clarithromycin resistance. All patients received an eradication therapy with either a standard 10-day triple therapy or a 10-day sequential regimen. The infection was considered cured when two consecutive UBTs were negative. Basal DOB values were categorized as low (<16), intermediate (16-35), or high (>35). A total of 282 patients were selected. Eradication rates did not differ between patients with high and low DOB values. No significant difference in DOB values emerged between patients infected with clarithromycin-susceptible and clarithromycin-resistant strains. Under multivariate analysis, DOB values did not influence the bacterial eradication, which was significantly affected only by the presence of clarithromycin resistance. This large analysis failed to demonstrate a role for DOB value in H. pylori eradication with either a 10-day triple or sequential therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597398     DOI: 10.1007/s10620-007-9893-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

Review 1.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?

Authors:  J P Gisbert; D Olivares; I Jimenez; J M Pajares
Journal:  Dig Liver Dis       Date:  2005-11-22       Impact factor: 4.088

3.  Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials.

Authors:  L Laine; M B Fennerty; M Osato; J Sugg; L Suchower; P Probst; J G Levine
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

4.  Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?

Authors:  G Maconi; F Parente; A Russo; L Vago; V Imbesi; G Bianchi Porro
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

5.  Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy.

Authors:  Ai-Wen Kao; Hsiu-Chi Cheng; Bor-Shyang Sheu; Ching-Yih Lin; Ming-Jen Sheu; Hsiao-Bai Yang; Jiunn-Jong Wu
Journal:  J Gen Intern Med       Date:  2005-02       Impact factor: 5.128

6.  Delta13CO2 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [13C] urea breath test.

Authors:  Francesco Franceschi; Alessandro Armuzzi; Filippo Cremonini; Emilia Carloni; Maria Assunta Zocco; Simona Di Caro; Cristiano Padalino; Robert M Genta; Paolo Pola; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

7.  Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'.

Authors:  F Perri; M R Villani; V Festa; M Quitadamo; A Andriulli
Journal:  Aliment Pharmacol Ther       Date:  2001-07       Impact factor: 8.171

8.  Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers.

Authors:  Yung-Chih Lai; Jyh-Chin Yang; Shih-Hung Huang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

9.  Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.

Authors:  Giuseppe Scaccianoce; Cesare Hassan; Alba Panarese; Donato Piglionica; Sergio Morini; Angelo Zullo
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522

10.  Can the C-14 urea breath test replace follow-up endoscopic biopsies in patients treated for Helicobacter pylori infection?

Authors:  V Ahuja; C S Bal; M P Sharma
Journal:  Clin Nucl Med       Date:  1998-12       Impact factor: 7.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.